image
Healthcare - Biotechnology - NASDAQ - US
$ 8.01
-7.29 %
$ 1.1 B
Market Cap
-2.12
P/E
INCOME STATEMENT
86.2 M REVENUE
-94.55%
-684 M OPERATING INCOME
-82.14%
-615 M NET INCOME
-119.24%
EFFICIENCY
Earnings Waterfall Vir Biotechnology, Inc.
image
Revenue 86.2 M
Cost Of Revenue 2.76 M
Gross Profit 83.4 M
Operating Expenses 768 M
Operating Income -684 M
Other Expenses -69.2 M
Net Income -615 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 86.2 1 580.5 1 087.1 67.2 0.7 0.9 0.1
GROSS PROFIT
Cost Of Revenue 2.8 146.3 65.9 301.6 148.5 100.2 62.5
Gross Profit 83.4 1 434.2 1 021.2 (234.3) (147.8) (99.4) (62.4)
OPERATING INCOME
Operating Expenses 767.7 601.1 600.5 364.2 178.7 119.6 81.6
Selling, General and Administrative Expenses 174.0 161.8 160.8 70.9 37.6 29.1 21.7
Research and Development Expenses 589.7 474.6 448.0 302.4 148.5 100.2 62.5
Operating Income (684.3) 833.1 276.9 (297.0) (178.0) (118.7) (81.5)
PRE-TAX INCOME
Interest Income Expense 0 183.1 0 0 0 0 0
Total Other Income 56.1 (78.8) 129.1 (1.6) 3.5 2.3 0.7
Pre-Tax Income (628.2) 754.3 549.8 (298.6) (174.5) (116.4) (80.8)
NET INCOME
Tax Provision (13.1) 238.4 21.2 54 K 0.2 (0.5) (10.9)
Net Income (615.1) 515.8 528.6 (298.7) (174.7) (115.9) (69.9)
EPS 4.59 3.89 4.07 2.51 1.62 1.2 0.72